Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Bonomi, Philip

One or more keywords matched the following items that are connected to Bonomi, Philip

Item Type	Name
Concept	Carcinoma, Non-Small-Cell Lung
Concept	Carcinoma
Concept	Carcinoma, Hepatocellular
Concept	Carcinoma, Renal Cell
Concept	Carcinoma, Squamous Cell
Concept	Carcinoma, Large Cell
Concept	Carcinoma, Bronchogenic
Concept	Carcinoma, Intraductal, Noninfiltrating
Concept	Carcinoma, Small Cell
Concept	Small Cell Lung Carcinoma
Academic Article	Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
Academic Article	Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
Academic Article	PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
Academic Article	CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
Academic Article	Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
Academic Article	Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer.
Academic Article	Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
Academic Article	A multi-analyte serum test for the detection of non-small cell lung cancer.
Academic Article	Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
Academic Article	Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
Academic Article	Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.
Academic Article	Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Academic Article	Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
Academic Article	Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.
Academic Article	Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
Academic Article	Platinum/etoposide therapy in non-small cell lung cancer.
Academic Article	Combined modality therapy for stage III non-small cell lung carcinoma: results of treatment and patterns of failure.
Academic Article	Recent advances in etoposide therapy for non-small cell lung cancer.
Academic Article	Prognostic importance of subdividing clinically staged IIIa and IIIb patients with non-small-cell lung cancer.
Academic Article	Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment.
Academic Article	Carboplatin in non-small cell lung cancer: review of the Eastern Cooperative Oncology Group trial and comparison with other carboplatin trials.
Academic Article	Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Academic Article	Preoperative radiation therapy in regionally localized stage III non-small cell lung carcinoma: long-term results and patterns of failure.
Academic Article	Neoadjuvant treatment in locally advanced non-small cell lung cancer.
Academic Article	Combined modality therapy for locally advanced non-small cell lung carcinoma.
Academic Article	Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy.
Academic Article	Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer.
Academic Article	Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
Academic Article	A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Academic Article	Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinoma.
Academic Article	Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in stage III non-small cell lung cancer.
Academic Article	Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma.
Academic Article	Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma.
Academic Article	Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
Academic Article	Brief overview of combination chemotherapy in non-small-cell lung cancer.
Academic Article	Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Academic Article	Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer.
Academic Article	Modification of the effects of cytotoxic chemotherapy on the immune responses of cancer patients with a nonsteroidal, antiinflammatory drug, piroxicam. A pilot study of the Eastern Cooperative Oncology Group.
Academic Article	Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation.
Academic Article	Phase I trial of cisplatin and razoxane (ICRF-159) (NSC #119875) in advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Pilot Study.
Academic Article	Elevated creatine phosphokinase MB in a patient with neuroendocrine carcinoma of the colon--evidence for a tumor marker. Report of a case.
Academic Article	Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma.
Academic Article	A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
Academic Article	Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Academic Article	Response to megestrol in male breast carcinoma.
Academic Article	Neuroendocrine carcinoma of the cervix: implications for staging and therapy.
Academic Article	Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
Academic Article	Neuroendocrine small cell carcinomas in miscellaneous primary sites: implications for staging and therapy.
Academic Article	Provisional "normograms" for identifying adenocarcinomas of the prostate or colon and hepatocellular carcinoma derived from their distribution of proteins separated by two-dimensional electrophoresis.
Academic Article	Neuroendocrine carcinomas of the gastrointestinal tract.
Academic Article	Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article	Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Academic Article	Treatment of stage D prostatic carcinoma with megestrol acetate.
Academic Article	Combined modality treatment for stage III non-small cell lung cancer.
Academic Article	Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Academic Article	Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
Academic Article	Alteration of integrated optical density and intercellular structure after induction chemotherapy and survival in lung carcinoma patients treated surgically.
Academic Article	Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy.
Academic Article	Combined modality treatment using BID radiation for locally advanced non-small cell lung carcinoma.
Academic Article	Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study.
Academic Article	Radiation and simultaneous cisplatin in non-small cell lung cancer.
Academic Article	Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
Academic Article	Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).
Academic Article	Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
Academic Article	Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non-small cell lung cancer.
Academic Article	Cisplatin/etoposide vs paclitaxel/cisplatin/G-CSF vs paclitaxel/cisplatin in non-small-cell lung cancer.
Academic Article	Post-operative adjuvant therapy for non-small-cell lung cancer.
Academic Article	Recent advances with chemotherapy for NSCLC: the ECOG experience. Eastern Cooperative Oncology Group.
Academic Article	Eastern Cooperative Oncology Group experience with chemotherapy in advanced non-small cell lung cancer.
Academic Article	A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Academic Article	Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials.
Academic Article	Review of selected randomized trials in small cell lung cancer.
Academic Article	Review of paclitaxel/carboplatin in advanced non-small cell lung cancer.
Academic Article	Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin.
Academic Article	A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586).
Academic Article	Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
Academic Article	Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
Academic Article	Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
Academic Article	Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Academic Article	Chemoradiation in locally advanced non-small cell lung cancer.
Academic Article	Novel approaches for the treatment of non-small cell lung cancer.
Academic Article	What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.
Academic Article	Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
Academic Article	ZD0473 treatment in lung cancer: an overview of the clinical trial results.
Academic Article	Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
Academic Article	Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
Academic Article	Erlotinib: a new therapeutic approach for non-small cell lung cancer.
Academic Article	Epidermal growth factor receptor-targeted therapy and symptom improvement in non-small cell lung cancer.
Academic Article	Novel treatments in non-small cell lung cancer.
Academic Article	Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer.
Academic Article	Therapeutic advances in second-line treatment of advanced non-small-cell lung cancer.
Academic Article	Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.
Academic Article	Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.
Academic Article	Current strategies in the management of lung cancer.
Academic Article	Other compounds and targets in non-small cell lung cancer.
Academic Article	Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial.
Academic Article	Historic evidence and future directions in clinical trial therapy of solid tumors.
Academic Article	PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2.
Academic Article	Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC).
Academic Article	Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
Academic Article	Paclitaxel poliglumex (PPX, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer.
Academic Article	The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.
Academic Article	Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy.
Academic Article	Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors.
Academic Article	Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.
Academic Article	Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.
Academic Article	Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer.
Academic Article	The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib.
Academic Article	Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.
Academic Article	Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.
Academic Article	Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer.
Academic Article	A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.
Academic Article	Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials.
Academic Article	Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Academic Article	Treatment of locally advanced non-small cell lung cancer.
Academic Article	Locally advanced NSCLC: current state of the art, treatment and future directions.
Academic Article	Implications of key trials in advanced nonsmall cell lung cancer.
Academic Article	Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.
Academic Article	Epidermal growth factor receptor pathway.
Academic Article	Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors.
Academic Article	PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy.
Academic Article	Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.
Academic Article	Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer.
Academic Article	Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer.
Academic Article	A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.
Academic Article	PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Academic Article	Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
Academic Article	Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy.
Academic Article	Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer.
Academic Article	Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by?Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
Academic Article	Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Academic Article	Survival Prediction in Ambulatory Patients With Stage III/IV Non-Small Cell Lung Cancer Using the Palliative Performance Scale, ECOG, and Lung Cancer Symptom Scale.
Academic Article	Treatment of advanced squamous cell carcinoma of the lung: a review.
Academic Article	The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial.
Academic Article	Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients.
Academic Article	Clinicopathologic Features of Advanced Squamous NSCLC.
Academic Article	Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.
Academic Article	Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.
Academic Article	An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Academic Article	Severe Exacerbation of Myasthenia Gravis Associated with Checkpoint Inhibitor Immunotherapy.
Academic Article	Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.
Academic Article	Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum.
Academic Article	The serum-based VeriStrat? test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.
Academic Article	Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Academic Article	Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC).
Academic Article	Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Academic Article	Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers.
Academic Article	EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.
Academic Article	Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
Academic Article	Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis.
Academic Article	Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition.

Search Criteria

Carcinoma